Latest Generation Wavefront Guided Clinical And Patient Reported Outcomes Of High Myopic Patients

To analyse the clinical safety and efficacy along with patient reported outcomes of iDesign 2.0 in LASIK correction of high levels of Myopia.

Private Refractive Surgery (Optical Express)

Outcomes of 1500 patients with a higher level of preoperative myopia ranging from -6.00D to -11.00D. Patients underwent bilateral laser vision correction procedures using J&J iDesign 2.0 between May 2019 and December 2022. Monocular and binocular UCDVA scores, manifest refraction, and patient reported outcomes were recorded 1 day, 1 month and 3 months post operatively. Clinical assessments, including any complications, were recorded in the electronic medical record then extracted.

The total number of patients included was 1,500, 3,000 eyes, with pre-op refractive range of --6.00D to -11.00D with up to -5.00D of astigmatism.  Postoperatively, 82.1% had MSE within 0.5D of emmetropia. Additionally, 87.1% of patients had monocular UCDVA of 6/6 or better and 98.6% had 6/12 or better; 96.2% patients had binocular UCDVA of 6/6 or better and 99.7% had 6/9 or better. 0.2% had a loss in BCDVA of > 2 lines. 94.6% of patients reported very satisfied or satisfied.

iDesign 2.0 provides a safe and effective treatment option for visual correction of extreme levels of myopia. Postoperative visual gains in UCDVA were significant with high levels of patient reported satisfaction and recommendation. Complication rates were low and only 0.2% of patients recorded a loss of >2 lines BCDVA.